31 January 2019

Researchers of the Orthopaedic Research Laboratory of the Radboudumc, together with the LUMC, received a grant of €180k from the Innovatiefonds Zorgverzekeraars for clinical implementation of patient-specific computer models for fracture risk prediction in patients with bone metastases.

Patients with cancer can suffer from bone metastases in the femur. These bone metastases are usually very painful and increase the risk of a fracture. Treatment of bone metastases is based on the fracture risk: patients with a low fracture risk will be treated with radiotherapy for pain management, whereas patients with a high fracture risk are considered for preventive surgery. According to current clinical guidelines, fracture risk is assessed by measuring the size of the metastases on X-rays or CT scans. However, it appears that using this method, there are patients who receive unnecessary preventive surgery, as well as patients who fracture their femur although they were assessed as low risk.
 
Computer simulation
The research team of the Radboudumc, consisting of Nico Verdonschot, Esther Tanck and PhD candidate Florieke Eggermont, and Yvette van der Linden of the LUMC, developed a patient-specific computer simulation that can predict fracture risk in patients with bone metastases. This computer simulation calculates bone strength based on a CT scan, and appears to be better at estimating fracture risk in comparison to the clinical guidelines. Therefore, they received a grant of €180k from the Innovatiefonds Zorgverzekeraars to initiate clinical implementation of the computer model. The idea is that clinicians can order a computer simulation at the Orthopaedic Research Lab if they are unsure about the patient’s fracture risk. They will then receive a patient-specific fracture risk prediction based on the calculations, which can be used in the consultation with the patient to determine the best treatment option.
 
Florieke Eggermont, Esther Tanck and Nico Verdonschot are members of theme Reconstructive and regenerative medicine.

Related news items


Biomarkers found in COVID-19 patients support bradykinin hypothesis

29 May 2020

A study into inflammatory substances in the blood of COVID-19 patients supports the hypothesis that kinins could play a role in the respiratory problems experienced by critically ill COVID-19 patients in IC. This discovery, published at MedRxiv, could lead to the development of new treatments.

read more

Introducing OnePlanet Research Center webinar 5 June, 16:00 hrs.

29 May 2020

OnePlanet Research Center develops digital technologies to create a society in which everyone can live a healthy life and has access to healthy and sustainable food. Radboudumc and Radboud University are amongst the founding partners. Find out what OnePlanet can do for you in this online session.

read more

The impact of sex and gender in the COVID-19 pandemic

29 May 2020

The case study of Sabine Oertelt-Prigione, developed by the European Commission’s H2020 Expert Group to update and expand "Gendered Innovations/Innovation through Gender", examines the impact of sex and gender in the current COVID-19 pandemic.

read more

Terrestrial bacteria can grow on nutrients from space

26 May 2020

Researchers from the Radboudumc describe in an article in Astrobiology that bacteria can survive on an 'extraterrestrial diet', which affected their pathogenic potential.

read more

The new front line: big data podcast

22 May 2020

What role do big data and technology play in the fight against corona? What data can help save lives? How do you ensure that your personal health data is used safely? Among others, Peter-Bram 't Hoen explains.

read more

OARSI Basic Science Award for Peter van der Kraan

22 May 2020

Purpose of this Basic Science Award of the Osteoarthritis Research Society International (OARSI) is to stimulate fundamental research in the field of osteoarthritis. Congratulations Peter.

read more